Neuroute
Neuroute uses AI to design and optimize clinical trials, improving site selection, enrollment forecasting, and protocol planning. The company offers a no-code B2B SaaS platform that combines AI-driven analytics, enrollment modeling, automated protocol brief generation, and study-level operational planning for clinical trial sponsors and researchers. Core technologies include machine learning models for feasibility and predictive enrollment, plus an AI toolkit for study analytics and workflow automation. Launched in 2019, Neuroute serves life‑science organizations aiming to reduce trial timelines and has been recognized among top cancer tech startups and supported by the PharmStars network.
Neuroute
Neuroute uses AI to design and optimize clinical trials, improving site selection, enrollment forecasting, and protocol planning. The company offers a no-code B2B SaaS platform that combines AI-driven analytics, enrollment modeling, automated protocol brief generation, and study-level operational planning for clinical trial sponsors and researchers. Core technologies include machine learning models for feasibility and predictive enrollment, plus an AI toolkit for study analytics and workflow automation. Launched in 2019, Neuroute serves life‑science organizations aiming to reduce trial timelines and has been recognized among top cancer tech startups and supported by the PharmStars network.